Use of koumine in preparation of medicament for treatment of inflammatory bowel disease
US11925634B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 10, 2020 |
| Grant date | Mar 12, 2024 |
| Priority date | — |
| Expiry date | Jul 10, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel use of koumine, an alkaloid monomer from Gelsemium elegans Benth., or a pharmaceutically acceptable salt thereof, and more particularly to use of koumine or its pharmaceutically acceptable salt in the preparation of a medicament for the treatment of inflammatory bowel disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.